More about

Ibrutinib

News
December 09, 2024
3 min read
Save

First-line regimen improves PFS in chronic lymphocytic leukemia

First-line regimen improves PFS in chronic lymphocytic leukemia

SAN DIEGO — A multidrug combination significantly improved survival for certain patients with leukemia compared with standard chemoimmunotherapy, according to results of the randomized phase 3 AMPLIFY study.

News
December 07, 2024
4 min read
Save

Rilzabrutinib induces rapid, durable response in ITP, may become ‘new standard’

Rilzabrutinib induces rapid, durable response in ITP, may become ‘new standard’

SAN DIEGO — Rilzabrutinib induced “fast” and “persistent” platelet count expansion for heavily treated individuals with immune thrombocytopenia, according to results of the randomized phase 3 LUNA 3 study.

News
August 15, 2024
4 min read
Save

Medicare announces price cuts for 10 drugs in first round of drug price negotiations

Medicare announces price cuts for 10 drugs in first round of drug price negotiations

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.

News
July 08, 2024
3 min watch
Save

VIDEO: AI, big data may transform CLL treatment, prognosis

VIDEO: AI, big data may transform CLL treatment, prognosis

In a video interview, Matthew Cortese, MD, MPH, discusses how AI could transform the treatment landscape for CLL.

News
July 08, 2024
3 min watch
Save

VIDEO: ‘Mutual trust’ in long-term monitoring for patients with CLL

VIDEO: ‘Mutual trust’ in long-term monitoring for patients with CLL

In a video interview, Matthew Cortese, MD, MPH, discusses the importance of long-term monitoring in CLL care.

News
July 08, 2024
4 min watch
Save

VIDEO: Expert discusses strategies to combat infections in patients with CLL

VIDEO: Expert discusses strategies to combat infections in patients with CLL

In a video interview, Matthew Cortese, MD, MPH, discusses strategies to combat infections in CLL patients.

News
July 08, 2024
4 min watch
Save

VIDEO: ‘Plenty of options out there’ for relapsed/refractory CLL treatment

VIDEO: ‘Plenty of options out there’ for relapsed/refractory CLL treatment

In a video interview, Matthew Cortese, MD, MPH, discusses advances in treatments for relapse/refractory CLL.

News
July 08, 2024
4 min watch
Save

VIDEO: Tailoring initial treatment approach for CLL to patients’ molecular features

VIDEO: Tailoring initial treatment approach for CLL to patients’ molecular features

In a video interview, Matthew Cortese, MD, MPH, discusses how to approach initial treatment of CLL.

News
June 19, 2024
5 min read
Save

Multidrug regimen could be ‘curative’ option for aggressive lymphoma

Multidrug regimen could be ‘curative’ option for aggressive lymphoma

A simultaneous, multidrug, multi-targeted treatment regimen produced remissions in patients with certain types of relapsed or refractory diffuse large B-cell lymphoma in a phase 1b/phase 2 study.

News
February 07, 2024
2 min read
Save

‘Aggressive’ combination therapy lowers blood pressure in patients receiving ibrutinib

‘Aggressive’ combination therapy lowers blood pressure in patients receiving ibrutinib

The combination treatment of two or more antihypertensive therapies in patients being treated with ibrutinib can significantly reduce blood pressure, data published in Blood Advances showed.

View more